Acticor Biotech: ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of August 31, 2022
Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today